Streetbeat News

Stock Prices

XOM

Exxon Mobil (NYSE:XOM) has seen significant options trading activity, with a split sentiment of 41% bullish and 41% bearish. The options trades suggest a targeted price range of $105 to $120. Analysts have mixed ratings, with target prices ranging from $120 to $149.

Portfolio Pulse from Benzinga Insights

September 25, 2024 | 5:30 pm

ACN

Accenture has seen significant bullish options trading activity, with 70% of traders showing positive sentiment. Analysts have set price targets ranging from $329 to $405, with the current stock price at $336.81. The company's earnings announcement is expected in one day.

Portfolio Pulse from Benzinga Insights

September 25, 2024 | 5:30 pm

AMZN

Unusual options activity for Amazon.com (AMZN) has been detected, with a significant number of bullish positions. This suggests potential positive movement in the stock. Analysts have mixed ratings, with price targets ranging from $230 to $265.

Portfolio Pulse from Benzinga Insights

September 25, 2024 | 5:30 pm

FTRE

Fortrea Holdings shares declined following a downgrade by Jefferies from Buy to Hold, with a reduced price target from $25 to $21.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 5:30 pm

BURL

Burlington Stores (NYSE:BURL) has significantly outperformed the market over the past decade, with an annualized return of 21.26%. A $100 investment in BURL 10 years ago would now be worth $680.93. This highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

September 25, 2024 | 5:30 pm

WSM

Williams-Sonoma (NYSE:WSM) has outperformed the market over the past 20 years with an average annual return of 10.9%, resulting in a $1000 investment growing to $7,910.05. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

September 25, 2024 | 5:30 pm

AMGN

LLY

SNY

Amgen's Phase 3 trial data for rocatinlimab in atopic dermatitis shows commercial potential despite competition. Goldman Sachs maintains a Buy rating with a $370 price target, noting the drug's safety profile and market potential. Amgen's stock is down 4.67% following the update.

Portfolio Pulse from Vandana Singh

September 25, 2024 | 5:30 pm

NNDM

Nano Dimension's shares rise following the announcement of its acquisition of Markforged for $475 million.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 5:24 pm

UCTT

Ultra Clean Holdings shares rose following Oppenheimer's initiation of coverage with an Outperform rating and a $70 price target.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 5:22 pm

META

Meta has announced the pricing for its Meta Quest 3 512GB at $499.99. This move is part of Meta's strategy to strengthen its position in the virtual reality market.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 5:21 pm